ProGenis Pharmaceuticals is focused on developing next generation RNA therapeutics that are more efficient, safer and accessible to treat inherited rare and acquired diseases. ProGenis is headquartered in Perth, Australia, and led by world-renowned experts with significant experience in RNA therapeutics including antisense oligonucleotide chemistries and manufacturing.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 3 Brodie-Hall Dr, Suite 7 & 10,australia
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.progenispharma.com
- HQ
- Bentley, Western Australia
Progenis Pharmaceuticals Questions
Progenis Pharmaceuticals's website is http://www.progenispharma.com
Progenis Pharmaceuticals's LinkedIn profile is https://au.linkedin.com/company/progenis-pharmaceuticals
Progenis Pharmaceuticals has
5 employees.
View email and phone details for 5
employees at Progenis Pharmaceuticals.
Progenis Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Progenis Pharmaceuticals's top competitors are
Anaxis Pharma,
Wa Life Sciences Innovation Hub,
Aspecthera,
Syngenis,
Rage Biotech,
Endo Axiom,
Inosi Therapeutics Pty Ltd,
Perron Institute,
Pyc Therapeutics (Asx: Pyc),
Ausbiotech.
Progenis Pharmaceuticals's categories are Pharmaceutical Manufacturing
Progenis Pharmaceuticals's founding year is 2021
